Globeflex Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,469
Closed -$322K 508
2020
Q4
$322K Hold
4,469
0.07% 335
2020
Q3
$204K Sell
4,469
-19,981
-82% -$835K 0.05% 358
2020
Q2
$1.1M Sell
24,450
-8,291
-25% -$371K 0.28% 113
2020
Q1
$1.26M Buy
32,741
+5,292
+19% +$244K 0.39% 66
2019
Q4
$1.27M Buy
27,449
+7,432
+37% +$322K 0.24% 139
2019
Q3
$815K Hold
20,017
0.18% 194
2019
Q2
$964K Sell
20,017
-12
-0.1% -$631 0.2% 165
2019
Q1
$1.25M Buy
20,029
+1,091
+6% +$74.9K 0.27% 118
2018
Q4
$1.13M Buy
18,938
+8,238
+77% +$495K 0.27% 114
2018
Q3
$690K Buy
10,700
+1,300
+14% +$72.5K 0.14% 258
2018
Q2
$423K Buy
9,400
+1,500
+19% +$59.8K 0.09% 322
2018
Q1
$245K Sell
7,900
-44
-0.6% -$1.45K 0.05% 376
2017
Q4
$238K Sell
7,944
-111,403
-93% -$3.23M 0.07% 299
2017
Q3
$3.94M Sell
119,347
-4,400
-4% -$152K 1.12% 5
2017
Q2
$4.14M Sell
123,747
-9,600
-7% -$286K 1.02% 6
2017
Q1
$3.86M Buy
133,347
+7,900
+6% +$196K 0.91% 5
2016
Q4
$2.8M Sell
125,447
-1,600
-1% -$31.3K 0.7% 11
2016
Q3
$2.36M Sell
127,047
-100
-0.1% -$1.89K 0.59% 20
2016
Q2
$2.07M Buy
127,147
+44
+0% +$647 0.57% 19
2016
Q1
$1.49M Hold
127,103
0.4% 54
2015
Q4
$1.49M Sell
127,103
-2,200
-2% -$27.8K 0.4% 55
2015
Q3
$1.58M Buy
129,303
+108,803
+531% +$1.39M 0.34% 72
2015
Q2
$193K Buy
20,500
+20,442
+35,245% +$189K 0.04% 377
2015
Q1
$1K Buy
+58
New +$586 ﹤0.01% 521

Other funds holding BEAT

Globeflex Capital's BEAT Position: Q1 2021 in Review

Globeflex Capital sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 4,469 shares — an estimated $322K sold.

Globeflex Capital first reported a position in BEAT in Q1 2015 and held it in 24 quarters. The position peaked at $4.14M in Q2 2017. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Globeflex Capital reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Globeflex Capital sold 4,469 BioTelemetry, Inc. shares in Q1 2021, an estimated $322K.
  • Globeflex Capital first reported a position in BioTelemetry, Inc. in Q1 2015 and held it in 24 quarters.
  • Globeflex Capital's BioTelemetry, Inc. position peaked at $4.14M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Globeflex Capital's 13F filing for Q1 2021, filed 14 May 2021.